Matthew Onsum
15Patents
6h-index
17Co-inventors
59Inventor score
Filing activity: Aug 17, 2009 → Feb 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9238080B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 22 | Active |
| US8691771B2 | Bi-specific fusion proteins for tissue repair | Chemistry; Metallurgy | 15 | Active |
| US9718892B2 | Method of treating myocardial infarction by administering a bi-specific fusion protein | Chemistry; Metallurgy | 8 | Active |
| US10407512B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 6 | Active |
| US8623592B2 | Methods and systems for predicting response of cells to a therapeutic agent | Chemistry; Metallurgy | 6 | Active |
| US9982060B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 6 | Active |
| US10040840B2 | Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue | Chemistry; Metallurgy | 5 | Active |
| US10633425B2 | Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5 | Chemistry; Metallurgy | 4 | Active |
| US10858450B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 4 | Active |
| US10988547B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 4 | Active |
| US11155593B2 | Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5 | Chemistry; Metallurgy | 3 | Active |
| US12122819B2 | Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant | Chemistry; Metallurgy | 0 | Active |
| US11879002B2 | Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof | Chemistry; Metallurgy | 0 | Active |
| US11673970B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US11814443B2 | Bi-specific fusion proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.